NFA
ETRM

Nationwide Fund Advisors’s EnteroMedics Inc. ETRM Stock Holding History

Nationwide Fund Advisors’s Portfolio ETRM Stock Details ETRM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q3 		– Sell
-14
Closed -$17K – 3373
2013
Q2 		$17K Buy
+14
New +$14.8K ﹤0.01% 3098

Other funds holding ETRM

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AAP
Ardsley Advisory Partners Stamford, Connecticut $960M AUM 207.76% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
William Blair & Company
William Blair & Company Chicago, Illinois $34.9B AUM 18.88% 1-Year Est. Return
B
Bailard Foster City, California $4.35B AUM 23.57% 1-Year Est. Return
WPC
White Pine Capital Bloomington, Minnesota $355M AUM 45.63% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
TMC
Trellus Management Company Delray Beach, Florida $72.8M AUM 4.5% 1-Year Est. Return

Nationwide Fund Advisors's ETRM Position: Q3 2013 in Review

Nationwide Fund Advisors sold out of EnteroMedics Inc. (ETRM) in Q3 2013, closing a stake of 14 shares — an estimated $17K sold.

Nationwide Fund Advisors first reported a position in ETRM in Q2 2013 and held it in 1 quarter. The position peaked at $17K in Q2 2013. 42 funds tracked by Wall St. Rank hold ETRM as of Q3 2013.

  • Nationwide Fund Advisors reported no remaining EnteroMedics Inc. position as of Q3 2013 after selling out during the quarter.
  • Nationwide Fund Advisors sold 14 EnteroMedics Inc. shares in Q3 2013, an estimated $17K.
  • Nationwide Fund Advisors first reported a position in EnteroMedics Inc. in Q2 2013 and held it in 1 quarter.
  • Nationwide Fund Advisors's EnteroMedics Inc. position peaked at $17K in Q2 2013.
  • 42 funds tracked by Wall St. Rank held EnteroMedics Inc. as of Q3 2013.

Based on Nationwide Fund Advisors's 13F filing for Q3 2013, filed 6 Nov 2013.